We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$992B
AUM Growth
-$120B
Cap. Flow
-$16.9B
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.94%
Holding
3,085
New
108
Increased
1,637
Reduced
1,059
Closed
107

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$4.45B
2
JPM icon
JPMorgan Chase
JPM
+$2.22B
3
TEAM icon
Atlassian
TEAM
+$2.08B
4
NVDA icon
NVIDIA
NVDA
+$1.81B
5
AAPL icon
Apple
AAPL
+$1.67B

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Healthcare 17.19%
3 Consumer Discretionary 15.16%
4 Financials 10.74%
5 Communication Services 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCO icon
2001
Acco Brands
ACCO
$399M
$995K ﹤0.01%
124,339
+9,963
+9% +$82.6K
HLNE icon
2002
Hamilton Lane
HLNE
$5.69B
$994K ﹤0.01%
12,863
+4,891
+61% +$408K
SNTI icon
2003
Senti Biosciences Holdings
SNTI
$12M
$994K ﹤0.01%
10,067
CERS icon
2004
Cerus
CERS
$572M
$993K ﹤0.01%
180,858
+3,797
+2% +$21K
HAFC icon
2005
Hanmi Financial
HAFC
$956M
$993K ﹤0.01%
+40,351
New +$1.04M
TECK icon
2006
Teck Resources
TECK
$31.3B
$989K ﹤0.01%
24,480
+201
+0.8% +$7.19K
RIG icon
2007
Transocean
RIG
$6.39B
$987K ﹤0.01%
215,920
-25,400
-11% -$96.6K
TRIP icon
2008
TripAdvisor
TRIP
$1.26B
$984K ﹤0.01%
36,277
+2,900
+9% +$77.3K
HLTH
2009
DELISTED
Cue Health Inc. Common Stock
HLTH
$983K ﹤0.01%
+152,385
New +$1.38M
FELE icon
2010
Franklin Electric
FELE
$4.75B
$977K ﹤0.01%
11,764
-51
-0.4% -$4.38K
CNNE icon
2011
Cannae Holdings
CNNE
$675M
$973K ﹤0.01%
40,680
+4,746
+13% +$134K
WLL
2012
DELISTED
Whiting Petroleum Corporation
WLL
$968K ﹤0.01%
11,881
+5,498
+86% +$416K
BTU icon
2013
Peabody Energy
BTU
$3.01B
$965K ﹤0.01%
39,346
-1,411
-3% -$23.9K
EPAY
2014
DELISTED
Bottomline Technologies Inc
EPAY
$963K ﹤0.01%
16,998
-1,139
-6% -$64.4K
KMT icon
2015
Kennametal
KMT
$2.35B
$958K ﹤0.01%
33,468
+1,805
+6% +$59.3K
TRMK icon
2016
Trustmark
TRMK
$2.79B
$956K ﹤0.01%
31,451
+1,261
+4% +$40.8K
WLY icon
2017
John Wiley & Sons Class A
WLY
$2.63B
$954K ﹤0.01%
17,993
+1,462
+9% +$76.8K
NUS icon
2018
Nu Skin
NUS
$236M
$953K ﹤0.01%
19,913
+3,393
+21% +$168K
AGR
2019
DELISTED
Avangrid, Inc.
AGR
$952K ﹤0.01%
20,361
+8,797
+76% +$403K
BKD icon
2020
Brookdale Senior Living
BKD
$3B
$951K ﹤0.01%
134,832
-10,813
-7% -$66K
MBI icon
2021
MBIA
MBI
$254M
$950K ﹤0.01%
61,737
-793
-1% -$11.7K
NWBI icon
2022
Northwest Bancshares
NWBI
$2.31B
$950K ﹤0.01%
70,301
+2,747
+4% +$38.8K
LPSN icon
2023
LivePerson
LPSN
$35.9M
$948K ﹤0.01%
2,587
+287
+12% +$116K
CALX icon
2024
Calix
CALX
$2.51B
$946K ﹤0.01%
22,046
+4,204
+24% +$213K
UFCS icon
2025
United Fire Group
UFCS
$1.37B
$945K ﹤0.01%
30,426
+4,912
+19% +$130K

Similar funds

T. Rowe Price Associates's Q1 2022 Portfolio in Review

As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
  • T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
  • T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
  • T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
  • T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
  • T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.

Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.